ArticleFrontiers of medicine2025

TRIM4 modulates the ubiquitin-mediated degradation of hnRNPDL and weakens sensitivity to CDK4/6 inhibitor in ovarian cancer.

Xiaoxia Che et al.PubMed ↗Publisher ↗

No numbers read from the abstract.